CHOLESTEROL REDUCTION EFFECTS ON BEHAVIOR
CHOLESTEROL REDUCTION EFFECTS ON BEHAVIOR
批准号:
6183192
负责人:
MATTHEW F MULDOON
金额:
$43.46万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-02-01 至 2002-04-30
关键词:
antihypercholesterolemic agent behavior test behavioral /social science research tag behavioral medicine cardiovascular disorder chemotherapy clinical research clinical trials cognition dosage drug adverse effect health behavior human subject human therapy evaluation hypercholesterolemia job performance longitudinal human study memory neuropsychological tests performance psychometrics psychomotor function quality of life social behavior
中文摘要
描述:此申请是竞争续订的重新提交
研究降胆固醇药物对人体健康影响的建议
心理功能。当前的国家健康政策建议
广泛的血清胆固醇降低。然而,人们对此知之甚少。
潜在的认知、情感和行为后遗症
降胆固醇治疗。最初的主要目标是
项目是确定通过一种常见的药物降低胆固醇
(洛伐他汀)引起行为、认知或情绪的改变,相对于
接受安慰剂治疗的对照组。结果表明,使用
洛伐他汀在一系列认知指标上的表现恶化
功能,特别是注意力和精神运动速度的测量。至
确定这些发现是否值得公共卫生关注,
降低胆固醇的认知后遗症现在需要在
代表日常生活的复杂任务的背景。
在一项双盲、安慰剂对照的临床研究中,300名健康
患有高胆固醇血症的成年人将被随机分配到三组中的一组
治疗条件:辛伐他汀5 mg/d,辛伐他汀40 mg/d,
和安慰剂--为期六个月。该计划的主要目标
建议的研究是评估降胆固醇对健康的影响
患者在施加复杂认知要求的任务中的表现
类似于日常生活中经常遇到的情况。这个
测试电池的组成有:1)汽车驾驶(模拟),2)
日常记忆测试,3)就业前能力和表现测试,4)
社会认知和行为(通过标准化情景进行评估
演示文稿和重要其他评级),以及5)标准
神经心理测试(用于与先前的结果进行比较)。对.的使用
两种治疗强度将允许检查剂量反应。
降胆固醇程度与认知功能的关系
性能。
英文摘要
DESCRIPTION: This application is a resubmission of a competing continuation
proposal to study the effects of cholesterol-lowering medications on
psychological functions. Current national health policy recommends
widespread serum cholesterol reduction. However, little is known regarding
the potential cognitive, affective, and behavioral sequelae of
cholesterol-lowering treatments. The principal objective of the initial
project was to determine whether cholesterol lowering by a common medication
(lovastatin) caused alterations in behavior, cognition or mood, relative to
placebo-treated controls. The results indicate that treatment with
lovastatin worsens performance across a range of indices of cognitive
functioning, particularly measures of attention and psychomotor speed. To
determine whether these findings warrant public health concern, the
cognitive sequelae of cholesterol lowering now require re-examination in the
context of complex tasks representative of daily life.
In a double-blind, placebo-controlled clinical investigation, 300 healthy
adults with hypercholesterolemia will be randomly assigned to one of three
treatment conditions -- simvastatin 5 mg per day, simvastatin 40 mg per day,
and placebo -- for a period of six months. The principal objective of the
proposed research is to evaluate the effects of cholesterol lowering on
patients' performance on tasks that impose complex cognitive demands that
are analogous to situations encountered frequently in everyday life. The
components of the test battery are: 1) automobile driving (simulation), 2)
everyday memory tests, 3) pre-employment aptitude and performance tests, 4)
social cognition and behavior, (evaluated by standardized scenario
presentation and significant other ratings), and 5) standard
neuropsychological tests (for comparison with prior results). The use of
two treatment intensities will permit examination of the dose-response
relationship between the degree of cholesterol lowering and cognitive
performance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multilevel mobile health program to improve rural hypertension
-
批准号:10338415
-
项目类别:
-
资助金额:$72.58万
-
财政年份:2022
-
负责人:MATTHEW F MULDOON
-
依托单位:
Multilevel mobile health program to improve rural hypertension
-
批准号:10644984
-
项目类别:
-
资助金额:$71.6万
-
财政年份:2022
-
负责人:MATTHEW F MULDOON
-
依托单位:
Effect of Reducing Sedentary Behavior on Blood Pressure
-
批准号:10198014
-
项目类别:
-
资助金额:$61.05万
-
财政年份:2017
-
负责人:MATTHEW F MULDOON
-
依托单位:
Omega-3 Fatty Acids, Cardiovascular Risk and Behavior
-
批准号:8216010
-
项目类别:
-
资助金额:$33.61万
-
财政年份:2011
-
负责人:MATTHEW F MULDOON
-
依托单位:
EFFECTS OF OMEGA-3 FATTY ACIDS ON COGNITIVE PERFORMANCE
-
批准号:8090503
-
项目类别:
-
资助金额:$14.85万
-
财政年份:2009
-
负责人:MATTHEW F MULDOON
-
依托单位:
EFFECTS OF OMEGA-3 FATTY ACIDS ON COGNITIVE PERFORMANCE
-
批准号:7878003
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2009
-
负责人:MATTHEW F MULDOON
-
依托单位:
EFFECTS OF OMEGA-3 FATTY ACIDS ON COGNITIVE PERFORMANCE
-
批准号:8293389
-
项目类别:
-
资助金额:$7.42万
-
财政年份:2009
-
负责人:MATTHEW F MULDOON
-
依托单位:
EFFECTS OF OMEGA-3 FATTY ACIDS ON COGNITIVE PERFORMANCE
-
批准号:7648335
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2009
-
负责人:MATTHEW F MULDOON
-
依托单位:
Omega-3 Fatty Acids, Cardiovascular Risk and Behavior
-
批准号:7318147
-
项目类别:
-
资助金额:$30.39万
-
财政年份:2007
-
负责人:MATTHEW F MULDOON
-
依托单位:
Distress, Fish Oil, Inflammation, and Heart Disease
-
批准号:6958824
-
项目类别:
-
资助金额:$11.14万
-
财政年份:2005
-
负责人:MATTHEW F MULDOON
-
依托单位:
Distress, Fish Oil, Inflammation, and Heart Disease
-
批准号:7140283
-
项目类别:
-
资助金额:$10.88万
-
财政年份:2005
-
负责人:MATTHEW F MULDOON
-
依托单位:
Blood pressure, reactivity, metabolism and serotonin
-
批准号:6564892
-
项目类别:
-
资助金额:$15.94万
-
财政年份:2002
-
负责人:MATTHEW F MULDOON
-
依托单位:
CHOLESTEROL REDUCTION EFFECTS ON BEHAVIOR
-
批准号:2910545
-
项目类别:
-
资助金额:$42.74万
-
财政年份:1992
-
负责人:MATTHEW F MULDOON
-
依托单位:
CHOLESTEROL REDUCTION EFFECTS ON BEHAVIOR
-
批准号:2467659
-
项目类别:
-
资助金额:$39.97万
-
财政年份:1992
-
负责人:MATTHEW F MULDOON
-
依托单位:
EFFECTS OF CHOLESTEROL REDUCTION ON BEHAVIOR
-
批准号:3365432
-
项目类别:
-
资助金额:$32.71万
-
财政年份:1992
-
负责人:MATTHEW F MULDOON
-
依托单位:
CHOLESTEROL REDUCTION EFFECTS ON BEHAVIOR
-
批准号:6389167
-
项目类别:
-
资助金额:$34.2万
-
财政年份:1992
-
负责人:MATTHEW F MULDOON
-
依托单位:
EFFECTS OF CHOLESTEROL REDUCTION ON BEHAVIOR
-
批准号:3365433
-
项目类别:
-
资助金额:$39.34万
-
财政年份:1992
-
负责人:MATTHEW F MULDOON
-
依托单位:
CHOLESTEROL REDUCTION EFFECTS ON BEHAVIOR
-
批准号:2222818
-
项目类别:
-
资助金额:$56.07万
-
财政年份:1992
-
负责人:MATTHEW F MULDOON
-
依托单位:
CHOLESTEROL REDUCTION EFFECTS ON BEHAVIOR
-
批准号:2222819
-
项目类别:
-
资助金额:$42.67万
-
财政年份:1992
-
负责人:MATTHEW F MULDOON
-
依托单位:
SUPPLEMENT EFFECTS OF CHOLESTEROL REDUCTION ON BEHAVIOR
-
批准号:2222817
-
项目类别:
-
资助金额:$14.15万
-
财政年份:1992
-
负责人:MATTHEW F MULDOON
-
依托单位:
海外基金